Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
478 CHF | +0.84% | +4.32% | +35.14% |
Mar. 05 | Lonza, Epsilogen Report GMP Manufacturing of Ovarian Cancer Antibody | MT |
Feb. 06 | LONZA GROUP : Some mixed real-world effects |
- Stock
- Equities
- Stock Lonza Group AG - Swiss Exchange
- News Lonza Group AG